Lead Clinical Genetics QA Associate Staff Scientist, QIAGEN Digital Insights
BIOGRAPHY
Date: November 13, 2024 | Time: 7:00 AM (PST), 10:00 AM (EST), 4:00 PM (CET)
A game-changer for pharmacogenomics: One tool to decode drug response to variation in the genome
Speakers
-
Elias Hage, PhD
Associate Director, Global Product Management, QIAGEN Digital InsightsBIOGRAPHY
Event Date & Time
Date: November 13, 2024
Time: 7:00 AM (PST), 10:00 AM (EST), 4:00 PM (CET)
Abstract
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective drugs based on the unique genetic information of every individual?
In this webinar, learn about a game-changing solution for labs and pharmaceutical companies to rapidly and confidently translate complex pharmacogenomics (PGx) data into evidence-backed insights to inform therapeutic outcomes. QIAGEN Pharmacogenomic Insights (PGXI) is a new expert-curated knowledgebase solution that provides comprehensive access to verified and up-to-date data from multiple PGx sources, including the FDA, CPIC, DPWG, PharmVar, and PubMed. Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories, PGXI seamlessly integrates into existing or new workflows to automate the annotation of PGx data from all platforms, including NGS and arrays. Within minutes, users can retrieve a custom output of relevant information, including relevant conditions associated with queried genes of interest, relevant drug-gene associations, and curated literature evidence for alleles in question.
In this webinar, you will learn:
- How PGXI can help your lab efficiently and consistently identify medications associated with adverse effects.
- What expert-curated content sources are available in PGXI, eliminating the need to consult multiple databases and saving you significant time and money.
- How to use PGXI to seamlessly scale your PGXI workflow and stay at the cutting edge of PGx research.
Plus, if eligible, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...